Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Anatomic Stage II Breast Cancer AJCC v8: early-phase trial registry
40 of 74 indexed Anatomic Stage II Breast Cancer AJCC v8 trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #183 of 28,707 conditions by registered trial count.
74 US clinical trials · 40 currently recruiting · #183 of 28,707 conditions by registered trial count
Anatomic Stage II Breast Cancer AJCC v8: 74 US clinical trials tracked, 40 recruiting.
Anatomic Stage II Breast Cancer AJCC v8 is the subject of 74 registered US clinical trials on ClinicalTrials.gov, 40 of them currently open to new participants. 9 are in Phase 3-4 (later-stage) and 26 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 12 of these trials.
Enrollment posture brief
Registry condition anatomic-stage-ii-breast-cancer-ajcc-v8
OPEN 40 | RECR 54% | LATE 9 | EARLY 26 | RANK #183 | SPON 12
Volume-matched condition peers
Nearest open-share peer: Mental Health (54% recruiting · 63 trials)
Anatomic Stage II Breast Cancer AJCC v8 lists 40 open slots (54% of 74 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Anatomic Stage II Breast Cancer AJCC v8 on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Anatomic Stage II Breast Cancer AJCC v8 is recruiting above its size-band peers.
40 of 74 indexed trials (54.1%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Anatomic Stage II Breast Cancer AJCC v8 research.
M.D. Anderson Cancer Center accounts for 12 of 74 trials (16.2%). 22 distinct sponsors appear on at least one study for this condition label.
-
Typical Anatomic Stage II Breast Cancer AJCC v8 enrolment sits around 88 participants.
Median target enrolment is 88 among the 74 trials that report a genuine target (sentinel values excluded). 39 of those (52.7%) plan for fewer than 100 participants.
-
Anatomic Stage II Breast Cancer AJCC v8 research is mostly interventional.
66 interventional and 8 observational studies make up this index (89.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
74 total, page 2 of 2
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study
M.D. Anderson Cancer Center
NCT04754412
Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer
ECOG-ACRIN Cancer Research Group
NCT04001829
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
ECOG-ACRIN Cancer Research Group
NCT05710328
Phase III Study of 5tx vs 15tx of RT (X-rays or Protons) Including RNI in Breast Cancer Patients
Mayo Clinic
NCT04443413
Metformin and Nightly Fasting in Women With Early Breast Cancer
M.D. Anderson Cancer Center
NCT05023967
Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
M.D. Anderson Cancer Center
NCT07407920
Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer
Rutgers, The State University of New Jersey
NCT04871516
Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy
M.D. Anderson Cancer Center
NCT05049746
Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study
OHSU Knight Cancer Institute
NCT04993313
Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer
Ohio State University Comprehensive Cancer Center
NCT03786354
A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors
University of Washington
NCT06392789
Mindfulness Intervention for Improving Nutrition in the Digital Kitchen Among Stage I-III Breast Cancer Survivors, MIND Trial
Fred Hutchinson Cancer Center
NCT06643455
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer
University of Washington
NCT05455658
Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer
M.D. Anderson Cancer Center
NCT05025059
Prospective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM)
Ohio State University Comprehensive Cancer Center
NCT04537312
Tibetan Yoga in Improving Fatigue and Sleep in Participants With Stage I-III Breast Cancer
M.D. Anderson Cancer Center
NCT00507923
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
Ohio State University Comprehensive Cancer Center
NCT04862585
An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors
Ohio State University Comprehensive Cancer Center
NCT05012176
An Escape Room Intervention to Help Improve Breast Cancer Patients' Ability to Navigate Online Access to Nutrition Information
Fred Hutchinson Cancer Center
NCT06193070
Weight Bearing Exercise in Preventing Frailty in Stage I-IIIA Breast Cancer Survivors
University of Arizona
NCT03708055
Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer
Wake Forest University Health Sciences
NCT03505671
M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer
M.D. Anderson Cancer Center
NCT03620201
Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer
M.D. Anderson Cancer Center
NCT03774472
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer
Ohio State University Comprehensive Cancer Center
NCT04205903
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 8 |
| Phase 2 | 18 |
| Phase 3 | 8 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Anatomic Stage II Breast Cancer AJCC v8 records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Anatomic Stage II Breast Cancer AJCC v8 trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Anatomic Stage II Breast Cancer AJCC v8 page
74 registered trials, 40 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 40 Anatomic Stage II Breast Cancer AJCC v8 trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- M.D. Anderson Cancer Center sponsors the most Anatomic Stage II Breast Cancer AJCC v8 trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Anatomic Stage II Breast Cancer AJCC v8 condition card totals 74 registered trials; most-linked intervention Questionnaire Administration; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.